130 related articles for article (PubMed ID: 6998653)
1. Aminoaciduria--its relationship to vitamin D and parathyroid hormone.
Phillips ME
Crit Rev Clin Lab Sci; 1980; 12(3):215-39. PubMed ID: 6998653
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Effect of vitamin D deficiency on amino acid excretion in the phosphate-depleted rat.
Dabbagh S; Epley M; Diven W; Chen T; Virji M; Ellis D
Miner Electrolyte Metab; 1989; 15(5):283-90. PubMed ID: 2811786
[TBL] [Abstract][Full Text] [Related]
4. Renal tubular acidosis and amino-aciduria in osteomalacia of dietary or intestinal origin.
Muldowney FP; Freaney R; McGeeney D
Q J Med; 1968 Oct; 37(148):517-39. PubMed ID: 5696365
[No Abstract] [Full Text] [Related]
5. Aminoaciduria of vitamin D deficiency is independent of PTH levels and urinary cyclic AMP.
Dabbagh S; Chesney R; Gusowski N; Mathews MC; Padilla M; Theissen M; Slatopolsky E
Miner Electrolyte Metab; 1989; 15(4):221-32. PubMed ID: 2548072
[TBL] [Abstract][Full Text] [Related]
6. [Review of the concept of vitamin D "sufficiency and insufficiency"].
Gómez Alonso C; Naves Díaz M; Rodríguez García M; Fernández Martín JL; Cannata Andía JB
Nefrologia; 2003; 23 Suppl 2():73-7. PubMed ID: 12778859
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
[TBL] [Abstract][Full Text] [Related]
8. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD
Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483
[TBL] [Abstract][Full Text] [Related]
9. [Hyperparathyroidism masked by osteomalacia. Is vitamin D administration in every case of osteomalacia problem-free?].
Zuber M; Löliger M; Boner H; Haas HG
Schweiz Med Wochenschr; 1986 May; 116(19):642-7. PubMed ID: 3715442
[TBL] [Abstract][Full Text] [Related]
10. Hyperparathyroidism as the cause of hyperaminoaciduria and phosphaturia in human vitamin D deficiency.
Fraser D; Kooh SW; Scriver CR
Pediatr Res; 1967 Nov; 1(6):425-35. PubMed ID: 5583448
[No Abstract] [Full Text] [Related]
11. Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.
Malluche HH; Goldstein DA; Massry SG
J Clin Invest; 1979 Mar; 63(3):494-500. PubMed ID: 429568
[TBL] [Abstract][Full Text] [Related]
12. A survey of vitamin D deficiency in gastrointestinal and liver disorders.
Dibble JB; Sheridan P; Losowsky MS
Q J Med; 1984; 53(209):119-34. PubMed ID: 6546800
[TBL] [Abstract][Full Text] [Related]
13. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
[TBL] [Abstract][Full Text] [Related]
14. Aminoaciduria in chronic renal failure--its relationship to vitamin D and parathyroid status.
Phillips ME; Havard J; Otterud B
Am J Clin Nutr; 1980 Jul; 33(7):1541-5. PubMed ID: 6893104
[TBL] [Abstract][Full Text] [Related]
15. Severe vitamin D deficiency in a case of primary hyperparathyroidism caused by parathyroid lipoadenoma, effect of 25OHD3 treatment.
Coen G; Bondatti F; de Matteis A; Ballanti P; Mazzaferro S; Sardella D; Smacchi A
Miner Electrolyte Metab; 1989; 15(6):332-7. PubMed ID: 2615720
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
17. [Vitamin D: synthesis, metabolism, regulation, and an assessment of its deficiency in patients with chronic renal disease].
Spustová V; Dzúrik R
Vnitr Lek; 2004 Jul; 50(7):537-43. PubMed ID: 15323262
[TBL] [Abstract][Full Text] [Related]
18. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
19. Impaired renal function and aluminum metabolism.
Mayor GH; Burnatowska-Hledin MA
Fed Proc; 1983 Oct; 42(13):2979-83. PubMed ID: 6617895
[TBL] [Abstract][Full Text] [Related]
20. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
Ritz E; Kreusser W; Boland R; Bommer J
Klin Wochenschr; 1979 Oct; 57(19):1053-9. PubMed ID: 392179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
